UPDATE 1-GSK long-acting HIV injection succeeds in study
August 22, 2019 at 03:28 AM EDT
GlaxoSmithKline's prospective two-monthly two-drug injection to treat HIV was as effective as a monthly dose of the same regimen in maintaining viral suppression at 48 weeks in a late-stage study, the British drugmaker said on Thursday.
